William Alden, MD, PhD | Medical Peptide & Fatty Acid Series
Diagnostic, ACTH, and Radiolabeled Peptides
By William Alden, MD, PhD | Medical Peptide, Regenerative & Fatty Acid Series
Beyond therapy, peptides are workhorses of diagnosis—from adrenal-axis testing to molecular imaging that localizes tumors with high specificity. Many of the same receptor targets used for imaging are later exploited for radioligand therapy, creating a coherent test-and-treat paradigm.
Key Agents in This Class
Cosyntropin, corticotropin, corticorelin.
ACTH-axis peptides used to test adrenal cortisol reserve (cosyntropin stimulation test) and to help distinguish pituitary from ectopic causes of Cushing syndrome (corticorelin). FDA-approved diagnostics.
Vosoritide, difelikefalin, ecallantide.
Although primarily therapeutic, these are included for completeness: vosoritide (CNP analog) for achondroplasia, difelikefalin (kappa-opioid agonist) for dialysis-related pruritus, and ecallantide (kallikrein inhibitor) for hereditary angioedema attacks. All FDA-approved.
Gallium Ga-68 DOTATATE and copper Cu-64 DOTATATE.
Somatostatin-analog PET tracers for localizing neuroendocrine tumors. They pair with Lu-177 DOTATATE therapy.
Gallium Ga-68 PSMA-11 and flotufolastat F-18.
PSMA-targeted PET tracers for prostate-cancer localization, staging, and selection of patients for PSMA radioligand therapy.
Technetium Tc-99m tilmanocept.
A receptor-targeted agent for sentinel lymph-node mapping in breast cancer, melanoma, and head-and-neck cancer.
Evidence and Regulatory Status
This group is essentially entirely FDA-approved. The imaging tracers frequently form the diagnostic half of a test-and-treat pair with matching radiotherapeutics. Endocrine diagnostic peptides remain indispensable for accurate adrenal and pituitary evaluation.
Frequently Asked Questions
What is a test-and-treat pairing?
An imaging tracer identifies tumors that express a given target; a matching therapeutic radioligand then delivers treatment to those same targets.
Why use peptide PET tracers?
A receptor-targeting peptide can localize disease with high specificity, guiding both diagnosis and subsequent therapy selection while minimizing non-specific background.
How does the cosyntropin test work?
Synthetic ACTH(1-24) is administered and serial cortisol levels are measured. An inadequate rise indicates primary or secondary adrenal insufficiency.
Clinical Perspective
Diagnostic peptides rarely generate headlines, yet they are indispensable. Their pairing with targeted therapy is one of the clearest working examples of precision medicine in routine practice.
Read more about this: [Reproductive Health: GnRH Agents and Fertility Peptides] and [Obstetric and Oxytocin Peptides].
About the Author
William “Wes” Alden, MD, PhD, is a physician-scientist and internist whose career spans academic medicine, federal clinical research, community healthcare, and medical philanthropy. His work sits at the intersection of laboratory science and bedside care, and his writing consistently returns to one theme: regenerative and metabolic therapies deserve both open-minded use and rigorous scientific and regulatory scrutiny. This series surveys the major categories of therapeutic peptides and healthful fatty acids, one blog at a time, with an emphasis on honest evidence and clear regulatory status.
Important Disclosure and Disclaimer
This content is for general education and reflects Dr. Alden’s professional perspective. It is not medical advice and does not create a doctor-patient relationship. Individual results vary, and many agents discussed are not FDA-approved for the uses described. Several peptides are not FDA-approved and have an evolving federal compounding status; products labeled for research use only are never appropriate for use in people. Most fatty acids discussed are foods or dietary supplements and are not FDA-approved to treat any condition. Any peptide or compounded agent should be used only through a licensed provider, with appropriately sourced pharmaceutical-grade material. Readers should consult a qualified healthcare professional about their own situation before pursuing any treatment.
Educational content reflecting Dr. Alden’s professional perspective. Not medical advice. Several agents named are not FDA-approved and some have an evolving compounding status. See the full disclosure accompanying this series.

November 20, 2026
4 min read




Back to Blog